CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 146 enrolled
Drug / intervention
AirCare Appbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02312765
NCT02312765N/ACompleted
CompareCT.gov

Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence

University of Pennsylvania·interventional·Posted Dec 9, 2014·Updated Aug 4, 2020

In Brief

A clinical study evaluating AirCare App for Congestive Heart Failure and Sleep Apnea Syndromes. Completed, enrolled 146 participants.

Detailed Summary

Sleep apnea, characterized by abnormal breathing at night, is often untreated in patients with heart failure. Helping patients to effectively use the most common form of treatment for sleep apnea, positive airway pressure therapy, can improve their heart function. This can reduce the likelihood that the patient will be re-admitted to the hospital. AirCareLabs has developed an innovative solution that allows patients to communicate with health care providers 24 hours a day, thus allowing them to get the help they need to effectively use positive airway pressure and thereby reduce the risk of being re-admitted to the hospital.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCongestive Heart Failure, Sleep Apnea Syndromes
Countries--
CollaboratorsAirCare Labs, LLC

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 9, 2014
Enrollment StartNov 1, 2014
Primary CompletionJun 1, 2017
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 11.6 years ago

Interventions

AirCare Appbehavioral

Tablet software to encourage adherence and support